Precision BioSciences, Inc. (DTIL)

NCM – Цена в реальном времени. Валюта: USD

7.42

-0.09 (-1.20%)

Рынок открыт: Aug 12, 2026, 3:03 PM EDT

7.51

0.00 (0.00%)

Предыдущая сессия: Aug 11, 2026, 7:34 PM EDT

06.08.2026

Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today reported financial results for the second quarter ended June 30, 2026, and provided a business update. “The second quarter marked a defining moment for Precision BioSciences and the hepatitis B field, with the first clinical biopsy evidence that a therapeutic.

Видео

No Data

There is no data to display

Пресс-релизы

06.08.2026

Precision BioSciences, Inc. (DTIL)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Precision BioSciences, Inc. (DTIL)

Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Видео

No Data

Пресс-релизы

Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Видео

No Data

Пресс-релизы

Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Search stocks

Precision BioSciences, Inc. (DTIL)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Precision BioSciences, Inc. (DTIL)

Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Видео

No Data

Пресс-релизы

Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Видео

No Data

Пресс-релизы

Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update